Spots Global Cancer Trial Database for A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma
Official Title: An Open-Label, Multicenter, Phase I Trial Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma
Study ID: NCT04434469
Interventions
Study Description
Brief Summary: This is a first-in-human Phase I, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, and pharmacokinetics of RO7297089 and make a preliminary assessment of anti-tumor activity in patients with R/R MM for whom no established therapy for MM is appropriate and available or who are intolerant to those established therapies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Concord Repatriation General Hospital, Concord, New South Wales, Australia
LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research, Liverpool, New South Wales, Australia
Royal Adelaide Hospital; Haematology Clinical Trials, Adelaide, South Australia, Australia
St. Vincent's Hospital Melbourne, Fitzroy, South Australia, Australia
Peter Mac Callum Cancer Center, East Melbourne, Victoria, Australia
UZ Gent, Gent, , Belgium
UZ Leuven, Leuven, , Belgium
Rigshospitalet, København Ø, , Denmark
Vejle Sygehus; Onkologisk Afdeling, Vejle, , Denmark
Oslo Universitetssykehus HF; Ullevål sykehus, Oslo, , Norway
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
